α3β1 Integrin-TargetingPolymersomal Docetaxel as an Advanced Nanotherapeutic for NonsmallCell Lung Cancer Treatment
Sign Up to like & getrecommendations! Published in 2020 at "ACS Applied Materials & Interfaces"
DOI: 10.1021/acsami.0c01069.s001
Abstract: Docetaxel (DTX) widely used for treating nonsmall cell lung cancer (NSCLC) patients is associated with dose-limiting side effects, especially neurotoxicity and myelosuppression. Here, we have developed cyclic cNGQGEQc peptide-directed polymersomal docetaxel (cNGQ-PS-DTX) as a targeted… read more here.
Keywords: cngq dtx; advanced nanotherapeutic; dtx; lung cancer ... See more keywords